Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology

Cancer Research

Volumn 65, Issue 16, 2005, Pages 7145-7150

  Myers Irvin, Julie M ^a   Van Le, Thu Suong ^a   Getzenberg, Robert H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1ALPHA; INTERLEUKIN 8; PROTEIN BLCA1; PROTEIN BLCA4; THROMBOMODULIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOBLOTTING; PATHOPHYSIOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STABILITY; SEQUENCE ANALYSIS; WESTERN BLOTTING;

CELL GROWTH PROCESSES; CELL LINE, TRANSFORMED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; NUCLEAR PROTEINS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 23844487365     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1142     Document Type: Article

References (17)

1. American Cancer Society. Cancer facts and figures. Vol. 2005. Washington (DC); 2005.
2. Al Sukhun S, Hussain M. Molecular biology of transitional cell carcinoma. Crit Rev Oncol Hematol 2003;47:181-93.
3. Kwak C, Ku JH, Park JY, Lee E, Lee SE, Lee C. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. J Urol 2004;171:149-52.
4. Van Le TS, Myers J, Konety BR, Barder T, Getzenberg RH. Functional characterization of the bladder cancer marker, BLCA-4. Clin Cancer Res 2004;10:1384-91.
5. Getzenberg RH, Konety BR, Oeler TA, et al. Bladder cancer-associated nuclear matrix proteins. Cancer Res 1996;56:1690-4.
6. Konety BR, Getzenberg RH. Nuclear structural proteins as biomarkers of cancer. J Cell Biochem 1999;32/33:183-91.
7. Leman ES, DeMiguel F, Gao AC, Getzenberg RH. Regulation of androgen and vitamin D receptors by 1,25-dihydroxyvitamin D3 in human prostate epithelial and stromal cells. J Urol 2003;170:235-40.
8. Tackels-Horne D, Goodman MD, Williams AJ, et al. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer 2001;92: 395-405.
9. Konety BR, Nguyen TS, Dhir R, et al. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin Cancer Res 2000;6:2618-25.
10. Seddighzadeh M, Steineck G, Jansson O, et al. Low interleukin-1α messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma. Br J Cancer 2001;84:329-34.
11. Inoue K, Slaton JW, Kim SJ, et al. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res 2000;60:2290-9.
12. Sheryka E, Wheeler MA, Hausladen DA, Weiss RM. Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma. Urology 2003;62:162-6.
13. Mian BM, Dinney CP, Bermejo CE, et al. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-κB. Clin Cancer Res 2003;9:3167-75.
14. Parker DC, Folpe AL, Bell J, et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 2003;27:1-10.
15. Iqbal S. Role of thrombomodulin in cancer biology. Breast 2000;9:264-6.
16. Khan N, Cromer CJ, Campa M, Patz EF. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer 2004;101:379-84.
17. Han SH, Jeon JH, Ju HR, et al. VDUP1 upregulated by TGF-β1 and 1,25-dihydroxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 2003;22:4035-46.